Targeted drugs for metastatic renal cell carcinoma
- PMID: 18156012
- DOI: 10.1016/S0140-6736(07)61874-1
Targeted drugs for metastatic renal cell carcinoma
Comment on
-
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.Lancet. 2007 Dec 22;370(9605):2103-11. doi: 10.1016/S0140-6736(07)61904-7. Lancet. 2007. PMID: 18156031 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
